Biotech

All Articles

Rivus' period 2 obesity-related cardiac arrest test attacks endpoint

.Rivus Pharmaceuticals has plumped up the prospects of its fat-busting, muscle-sparing medication pr...

Ovid standstills preclinical work, IV course after soticlestat fail

.Ovid Therapy already uncovered final month that it was trimming its own head count as the provider ...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston ma Seaport

.Eli Lilly has actually opened up a $700 thousand R&ampD facility in the Boston Seaport, enhancing i...

Boundless Bio makes 'modest' discharges five months after $100M IPO

.Merely five months after securing a $100 million IPO, Limitless Biography is actually presently giv...

Halda's $126M will definitely evolve 'hold as well as eliminate' lump medicines

.The initial stages of oncology R&ampD may not be short of fascinating new modalities, as well as Ha...

Lykos 'remorses' not making known study violations along with author

.Psychopharmacology has actually taken 3 posts concerning midstage professional test records determi...

Analysts explore Avidity's DMD succeed, disclosing nuances in records

.Avidity Biosciences satisfied investors with stage 1/2 data in Duchenne muscular dystrophy (DMD) Fr...

Actinogen's cortisol blocker fails phase 2 anxiety research study

.Actinogen Medical's cortisol blocker has missed the major endpoint of a period 2 study in anxiety, ...

Bivictrix determines going personal only way to take ADC in to center

.Antibody-drug conjugates (ADCs) have actually gone to the center of numerous a billion-dollar biobu...

TPG leadings up funds to $580M for financial investments across lifestyle sciences

.Property supervisor TPG, which has assisted biotechs like Sionna Therapies and also Santa Clam Ana ...